EXC
64
3
NUE
41
-2
VRSK
42
-5
RF
53
5
AIZ
56
7
AXP
67
4
MSI
47
4
MDLZ
22
6
SCHW
42
2
XRX
45
-3
SYF
71
7
CRM
59
4
TRIP
67
7
LOW
46
4
APD
60
3
PFE
37
-5
PVH
39
2
LUV
48
3
CINF
31
3
LH
45
2
EXC
64
3
NUE
41
-2
VRSK
42
-5
RF
53
5
AIZ
56
7
AXP
67
4
MSI
47
4
MDLZ
22
6
SCHW
42
2
XRX
45
-3
SYF
71
7
CRM
59
4
TRIP
67
7
LOW
46
4
APD
60
3
PFE
37
-5
PVH
39
2
LUV
48
3
CINF
31
3
LH
45
2
Financhill
Back

SpringWorks Therapeutics Stock Predictions

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free
Sell
9

SWTX
SpringWorks Therapeutics

Last Price:
$32.50
Seasonality Move:
-2.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free

SpringWorks Therapeutics Stock Forecast

  • Over the next 52 weeks, SpringWorks Therapeutics has on average historically risen by 13% based on the past 5 years of stock performance.
  • SpringWorks Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is SpringWorks Therapeutics Stock Undervalued?
    The current SpringWorks Therapeutics [SWTX] share price is $32.50. The Score for SWTX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will SpringWorks Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, SpringWorks Therapeutics has on average historically risen by 13% based on the past 5 years of stock performance.

SpringWorks Therapeutics Stock Rating

Sell
9
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics overpriced?

  • SpringWorks Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

SpringWorks Therapeutics Stock Price History

Is SWTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
springworkstx.com

52-Week Data

52-Week High:
53.92
52-Week Low:
28.21

Prediction Charts

Market Cap:
2.4B
Price in USD:
32.50
Volume:
2.7M
Beta:
0.92

Technical Analysis

SMA50:
37.33
SMA100:
36.01
SMA200:
38.27
52-Wk Change:
-20.6%

Stock Predictions

  • Is SpringWorks Therapeutics stock public?
    Yes, SpringWorks Therapeutics is a publicly traded company.
  • What is the SpringWorks Therapeutics stock quote today?
    The SpringWorks Therapeutics stock price is 32.50 USD today.
  • How to buy SpringWorks Therapeutics stock online?
    You can buy SpringWorks Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-23 35.47 37.37 37.80 35.12
Dec-24 37.33 36.81 37.60 36.59
Dec-26 36.56 37.14 37.38 36.20
Dec-27 36.82 36.35 37.40 35.73
Dec-30 35.95 36.34 36.93 35.39
Dec-31 36.43 36.13 36.90 35.91
Jan-2 36.32 36.08 37.88 35.99
Jan-3 36.11 38.19 38.57 36.11
Jan-6 38.21 38.86 40.03 37.77
Jan-7 38.80 41.20 45.65 37.90
Jan-8 40.89 40.49 42.30 39.74
Jan-10 39.78 43.00 44.01 38.43
Jan-13 38.50 37.01 39.44 35.22
Jan-14 37.36 32.50 38.25 32.38

SpringWorks Therapeutics Earnings

SpringWorks Therapeutics Earnings Report: Per Share SpringWorks Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

SpringWorks Therapeutics Forecast Revenue Growth

SpringWorks Therapeutics Stock Analysis: Historical quarterly revenues per share for SpringWorks Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $1.33 per share.

* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.